No Data
Lake Street Maintains Connect Biopharma(CNTB.US) With Buy Rating, Maintains Target Price $9
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Connect Biopharma Holdings (CNTB)
Oppenheimer Initiates Connect Biopharma(CNTB.US) With Buy Rating, Announces Target Price $8
Connect Biopharma Holdings (CNTB) Receives a New Rating From Oppenheimer
Connect Biopharma Shares Are Trading Higher After Oppenheimer Initiated Its Coverage on the Stock With a Outperform Rating and Announced a Price Target of $8.
Express News | Connect Biopharma Shares Are Trading Higher After Oppenheimer Initiated Its Coverage on the Stock With a Outperform Rating and Announced a Price Target of $8
Blvckwood : thanks your posts help alot
Riyan5426 : Thank you![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
76338690 : thank you
SPACE GHOST 7777 :


